[Congressional Record Volume 172, Number 106 (Wednesday, June 24, 2026)]
[Senate]
[Page S3356]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 6165. Ms. HIRONO submitted an amendment intended to be proposed by 
her to the bill S. 4784, to authorize appropriations for fiscal year 
2027 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

        At the appropriate place in title VII, insert the 
     following:

     SEC. 7__. INCLUSION OF COMPREHENSIVE CONTRACEPTIVE COUNSELING 
                   IN HEALTH ASSESSMENT FORMS.

       (a) In General.--Not later than 90 days after the date of 
     the enactment of this Act, the Secretary of Defense, in 
     consultation with the Secretary of Health and Human Services, 
     shall--
       (1) revise the periodic health assessment form of the 
     Department of Defense (Department of Defense Form 3024) to 
     include the information specified in subsection (b); and
       (2) revise the pre-deployment health assessment form of the 
     Department (Department of Defense Form 2795)--
       (A) to allow members of the Armed Forces to indicate they 
     would like comprehensive contraceptive counseling; and
       (B) to include the information specified in subsection (b).
       (b) Information Specified.--The information specified in 
     this subsection is the following:
       (1) An explanation of patient-centered contraceptive 
     counseling as recommended by the American College of 
     Obstetricians and Gynecologists, including by incorporating 
     any clinical guidance on contraceptive counseling set forth 
     by the American College of Obstetricians and Gynecologists.
       (2) A description of the full range of contraceptive 
     methods, including any contraceptive drug, device, or 
     biological product approved, cleared, authorized, or licensed 
     by the Food and Drug Administration under section 505, 
     510(k), 513(f)(2), 515, or 564 of the Federal Food, Drug, and 
     Cosmetic Act (21 U.S.C. 355, 360(k), 360c(f)(2), 360e, 
     360bbb-3) or section 351 of the Public Health Service Act (42 
     U.S.C. 262)).
       (3) Such other information relating to contraceptive 
     counseling as the Secretary of Defense determines 
     appropriate.
                                 ______